122 related articles for article (PubMed ID: 22564223)
1. Increased in vitro differentiation of fibrocytes from keloid patients is inhibited by serum amyloid P.
Naylor MC; Lazar DA; Zamora IJ; Mushin OP; Yu L; Brissett AE; Olutoye OO
Wound Repair Regen; 2012; 20(3):277-83. PubMed ID: 22564223
[TBL] [Abstract][Full Text] [Related]
2. Identification of fibrocytes from mesenchymal stem cells in keloid tissue: a potential source of abnormal fibroblasts in keloid scarring.
Iqbal SA; Sidgwick GP; Bayat A
Arch Dermatol Res; 2012 Oct; 304(8):665-71. PubMed ID: 22407077
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
4. First identification of resident and circulating fibrocytes in Dupuytren's disease shown to be inhibited by serum amyloid P and Xiapex.
Iqbal SA; Hayton MJ; Watson JS; Szczypa P; Bayat A
PLoS One; 2014; 9(6):e99967. PubMed ID: 24933153
[TBL] [Abstract][Full Text] [Related]
5. Keloid-derived fibroblasts have a diminished capacity to produce prostaglandin E2.
Yeh FL; Shen HD; Lin MW; Chang CY; Tai HY; Huang MH
Burns; 2006 May; 32(3):299-304. PubMed ID: 16487663
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion.
Ong CT; Khoo YT; Tan EK; Mukhopadhyay A; Do DV; Han HC; Lim IJ; Phan TT
J Pathol; 2007 Jan; 211(1):95-108. PubMed ID: 17136757
[TBL] [Abstract][Full Text] [Related]
7. Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts.
Carroll LA; Koch RJ
Med Sci Monit; 2003 Mar; 9(3):BR97-108. PubMed ID: 12640331
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
9. Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro.
Chipev CC; Simman R; Hatch G; Katz AE; Siegel DM; Simon M
Cell Death Differ; 2000 Feb; 7(2):166-76. PubMed ID: 10713731
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis.
Zhang GY; Cheng T; Luan Q; Liao T; Nie CL; Zheng X; Xie XG; Gao WY
Br J Dermatol; 2011 Apr; 164(4):729-37. PubMed ID: 21070203
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of fibrocyte differentiation by serum amyloid P.
Pilling D; Buckley CD; Salmon M; Gomer RH
J Immunol; 2003 Nov; 171(10):5537-46. PubMed ID: 14607961
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis.
Dillingh MR; van den Blink B; Moerland M; van Dongen MG; Levi M; Kleinjan A; Wijsenbeek MS; Lupher ML; Harper DM; Getsy JA; Hoogsteden HC; Burggraaf J
Pulm Pharmacol Ther; 2013 Dec; 26(6):672-6. PubMed ID: 23380438
[TBL] [Abstract][Full Text] [Related]
13. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
14. A brief exposure to tryptase or thrombin potentiates fibrocyte differentiation in the presence of serum or serum amyloid p.
White MJ; Galvis-Carvajal E; Gomer RH
J Immunol; 2015 Jan; 194(1):142-50. PubMed ID: 25429068
[TBL] [Abstract][Full Text] [Related]
15. [Allocation and identification of fibrocytes from human peripheral blood].
Skorobogataia EV; Kalmykova NV; Blinova MI; Pinaev GP
Tsitologiia; 2008; 50(2):118-23. PubMed ID: 18540191
[TBL] [Abstract][Full Text] [Related]
16. Elevated interleukin-6 expression in keloid fibroblasts.
Xue H; McCauley RL; Zhang W
J Surg Res; 2000 Mar; 89(1):74-7. PubMed ID: 10720455
[TBL] [Abstract][Full Text] [Related]
17. Circulating fibrocytes--biology and mechanisms in wound healing and scar formation.
Grieb G; Steffens G; Pallua N; Bernhagen J; Bucala R
Int Rev Cell Mol Biol; 2011; 291():1-19. PubMed ID: 22017972
[TBL] [Abstract][Full Text] [Related]
18. Decreased production of MCP-1 and MMP-2 by keloid-derived fibroblasts.
Yeh FL; Shen HD; Tai HY
Burns; 2009 May; 35(3):348-51. PubMed ID: 18950946
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts.
Yoshimoto H; Ishihara H; Ohtsuru A; Akino K; Murakami R; Kuroda H; Namba H; Ito M; Fujii T; Yamashita S
Am J Pathol; 1999 Mar; 154(3):883-9. PubMed ID: 10079266
[TBL] [Abstract][Full Text] [Related]
20. Enhanced MCP-1 release by keloid CD14+ cells augments fibroblast proliferation: role of MCP-1 and Akt pathway in keloids.
Liao WT; Yu HS; Arbiser JL; Hong CH; Govindarajan B; Chai CY; Shan WJ; Lin YF; Chen GS; Lee CH
Exp Dermatol; 2010 Aug; 19(8):e142-50. PubMed ID: 20100200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
